Hydroxyurea use in sickle cell disease: the battle with low prescription rates, poor patient compliance and fears of toxicities
2010; Taylor & Francis; Volume: 3; Issue: 3 Linguagem: Inglês
10.1586/ehm.10.22
ISSN1747-4086
AutoresAmanda M. Brandow, Julie A. Panepinto,
Tópico(s)Epigenetics and DNA Methylation
ResumoSickle cell disease (SCD) is the most common inherited blood disorder in the USA, affecting approximately 89,000 Americans or one in 400 African–Americans [1]. SCD is caused by inheritance of the s...
Referência(s)